
基本信息:
- 专利标题: USE OF PROLACTIN AS A TGF-BETA ANTAGONIST
- 专利标题(中):使用如催乳素TGF-β拮抗剂
- 申请号:EP97921467.0 申请日:1997-04-30
- 公开(公告)号:EP0921809A1 公开(公告)日:1999-06-16
- 发明人: MCPHERSON, John, J. , RICHARDS, Susan, M.
- 申请人: Genzyme Corporation
- 申请人地址: No. 1 Mountain Road, P.O. Box 9322 Framingham, MA 01701-9322 US
- 专利权人: Genzyme Corporation
- 当前专利权人: Genzyme Corporation
- 当前专利权人地址: No. 1 Mountain Road, P.O. Box 9322 Framingham, MA 01701-9322 US
- 代理机构: Froud, Clive, et al
- 优先权: US19960016492P 19960430
- 国际公布: WO1997040848 19971106
- 主分类号: A61K31
- IPC分类号: A61K31 ; A61K38 ; A61P1 ; A61P11 ; A61P37 ; A61P43
摘要:
This invention is based upon the discovery that prolactin has been found to counter the effect that TGF-β has on cells. An object of the present invention is to claim a method for treating a patient that may be suffering from a disease or disorder which is associated with the presence of TGF-β, by administering an effective amount of a pharmaceutically acceptable composition containing prolactin.